What's Happening?
The Michigan State Law Review hosted its annual symposium, 'Law, Policy, and the Next Era of Healthcare Reform,' on Friday, November 13, 2026, at Graduate by Hilton in East Lansing, Michigan. The event brought together four legal scholars to discuss how
rising healthcare costs, corporate influence, emerging technologies like artificial intelligence, and state and federal regulations are transforming the healthcare industry and challenging existing legal protections. Discussions included the impact of financing on patient care, exemplified by a case where a hospital allegedly lacked critical medical devices due to unpaid bills following private equity restructuring. Scholars also addressed the ethical implications of automated decision-making tools in insurance denials, racial disparities in organ transplantation, the history of eugenics, and the complexities of reproductive rights post-Dobbs v. Jackson Women’s Health Organization. The symposium also delved into conflicts between federal drug regulations and state laws authorizing unapproved treatments, as well as the potential benefits and risks of AI in healthcare.
Why It's Important?
This symposium is crucial for understanding the multifaceted challenges and evolving landscape of the U.S. healthcare system. The discussions highlight critical issues such as the financial pressures on healthcare providers, the ethical dilemmas posed by new technologies like AI in patient care and insurance, and the persistent problem of health disparities. The examination of conflicting state and federal regulations regarding treatments like medical marijuana and psilocybin underscores the legal complexities that can impact patient access and safety. The insights from legal scholars provide a framework for policymakers, healthcare professionals, and the public to consider necessary reforms and safeguards. Addressing these issues is vital for ensuring equitable access to quality healthcare, protecting patient rights, and adapting legal frameworks to keep pace with rapid advancements and economic shifts in the medical field.
What's Next?
The insights generated from this symposium are likely to inform ongoing debates and potential legislative efforts regarding healthcare reform. Policymakers may consider the scholars' recommendations for stronger regulation of corporate influence and automated decision-making tools in healthcare. The discussions on conflicting state and federal drug laws could prompt calls for clearer national guidelines or more robust public education campaigns regarding unapproved treatments. Furthermore, the exploration of AI's role in healthcare suggests a future need for regulatory 'sandboxes' to safely test new technologies, balancing innovation with patient safety and privacy. Continued dialogue among legal experts, healthcare providers, and government bodies will be essential to navigate these complex issues and shape the future of healthcare policy in the United States.
Beyond the Headlines
The symposium's focus on the intersection of law, policy, and healthcare reveals deeper societal implications. The case of Sungida Rashid, who allegedly died due to a hospital's lack of equipment following private equity restructuring, highlights the potential human cost of financial decisions in healthcare and raises questions about corporate accountability. The discussion on Frances Walter, whose rehabilitation coverage was denied based on an algorithm, underscores the growing ethical concerns surrounding AI in critical decision-making and the need for robust oversight to prevent algorithmic bias and ensure human oversight. Moreover, the examination of racial disparities in organ transplantation and the historical context of eugenics points to systemic inequalities that continue to plague the healthcare system, demanding comprehensive and equitable solutions beyond mere legal adjustments.
